These findings are consistent with the results that CD8hi Tregs induced in vitro with expression of CD25, Foxp3 and CTLA-4 alleviate GVHD without affecting general immunity and graft-versus-tumor activity (34). This evidence concerns the gene FOXP3 and graft versus host disease.